PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis.

Rat / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25890041 ↗2015Reported benefit

The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis.

RatOtherWistarn = n=40 RS-130830, n=42 vehicle controlintraperitoneal75 mg/kgstarted 3 h post infection

Model: Pneumococcal meningitis induced by intracisternal injection of live Streptococcus pneumoniae, with ceftriaxone started 18 h post infection

Cortical necrosis was significantly attenuated by RS-130830 while hippocampal apoptosis was unchanged. CSF IL-1beta and IL-10 at 18 h post infection were significantly lower, and weight loss and CSF leukocyte counts were significantly reduced in treated survivors.

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.